Global Hyaluronic Acid Market Research Report: Forecast (2021-2026)

Hyaluronic acid is a gooey and clear substance produced naturally by humans. It is present in the skin, eyes, and connective tissues. Hyaluronic acid works as a cushion to keep tissues and joints of the body lubricated and moist.
According to the The publisher ' research report, "Global Hyaluronic Acid Market Analysis, 2021," the market is expected to grow at a CAGR of around 8% between 2021-26. The growth of the Global Hyaluronic Acid Market is mounting to the aging population because of their joint pain and the rising prevalence of gingivitis and ulcers. Other factors like rising incidences of orthopedic diseases due to growth in the number of people suffering from obesity and the demand for the minimally invasive procedure project to grow in the hyaluronic acid market globally in the upcoming years.

Impact of COVID-19

The outbreak of the COVID-19 pandemic has brought the entire healthcare industry into the limelight and subsequently impacted the hyaluronic acid market. This downfall is due to a severe shortage of critical medical supplies and a rapid rise in COVID-19 cases. It further created a gap between the demand and supply of the market.
The stringent social distancing norms and restriction on movements appear to be an immediate effect on the market. However, post-COVID-19 lockdown, Hyaluronic Acid companies have started to strategize R&D investments and planning developing new products to enhance the performance and optimize the cost structure. Thus, the market is likely to grow substantially during the forecast period.

Market Segmentation

Cosmetic Grades Held the Largest Market Share
Based on the grade, the market classifies into cosmetic, pharmaceutical, and food grades. Among these grades, Cosmetic acquired the largest market share in the Global Hyaluronic Acid Market in 2019 owing to the launch of extensive hyaluronic-based cosmetic products, lifestyle changes, rising consumption of unhealthy food, and increasing pollution leading to skin disorders. Therefore, it is further presumed to drive the cosmetic grade segment growth in the Hyaluronic Acid market soon, reveals The publisher in their research report, "Global Hyaluronic Acid Market Analysis, 2021."
The Osteoarthritis Segment Likely to show Substantial Growth
Based on the application, the osteoarthritis segment is likely to witness the fastest growth between 2021-26 that attributes to a significant surge in the geriatric population, which is more susceptible to joints & bone issues. However, the increasing orthopedic problems tend to form degenerative-joint disorders due to wear & tear of the joint over time. Hence, the demand for hyaluronic acid-based products upsurge in the coming years, states The publisher in their research report, "Global Hyaluronic Acid Market Analysis, 2021."

Regional Landscape

Asia-Pacific is likely to grow considerably in the Global Hyaluronic Acid market during the forecast period. Japan likely to have the fastest growth as the country has numerous aged populations in the world. The demand for hyaluronic acid shall propel as bone-related problems are likely to be the highest soon. Moreover, constant change in healthcare services and an increase in R&D activities would drive the extension of the hyaluronic acid market in the forecast period.

Market Driver

The upsurge in the geriatric population is boosting the market growth.
The burgeoning number of aging populations is one of the prevalent factors driving the growth of the hyaluronic market. The elderly population is vulnerable to orthopedic problems like arthritis and osteoporosis, which increases the need for treatment, including hyaluronic acid. According to WHO, the world population above the 60s will double from 12% to 22% between 2015-2050. Hence, it is likely to fuel the market growth in the forecast period.

Competitive Landscape

According to The publisher , the major leading players in the Global Hyaluronic Acid Market are Allergan Plc, Anika Therapeutics Inc, Sanofi, Fidia Farmaceutici, Seikagaku Corporation, Ferring Pharmaceuticals, Contipro Corporation, Kewpie Corporation, etc.

Key Questions Answered in the Market Research Report:

1. What are the overall market statistics or market estimates (Market Overview, Market Size- By Value, Forecast Numbers, Market Segmentation, Market Shares) of the Global Hyaluronic Acid Market?
2. What is the region-wise industry size, growth drivers, and challenges?
3. What are the key innovations, opportunities, current & future trends, and regulations in the Global Hyaluronic Acid market?
4. Who are the key competitors, their key strengths &weaknesses, and how do they perform in the Global Hyaluronic Acid Market based on a competitive benchmarking matrix?
5. What are the key results derived from the market surveys conducted during the Global Hyaluronic Acid Market study?

1. Introduction

1.1. Product Definition
1.2. Research Process
1.3. Market Segmentation
1.4. Assumptions

2. Preface3. Executive Summary4. Impact of COVID-19 on Global Hyaluronic Acid Market

5. Global Hyaluronic Acid Market Dynamics

5.1. Growth Drivers
5.2. Challenges
5.3. Impact Analysis

6. Global Hyaluronic Acid Market Policies and Product Standards7. Global Hyaluronic Acid Market Trends & Insights8. Global Hyaluronic Acid Market Hotspot & Opportunities9. Global Hyaluronic Acid Market Key Strategic Imperatives for Success & Growth

10. Global Hyaluronic Acid Market Outlook, 2016-2026F

10.1. Market Size & Analysis
10.1.1. Revenues
10.2. Market Share & Analysis
10.2.1. By Grade
10.2.1.1. Cosmetic Grade
10.2.1.2. Pharmaceutical Grade
10.2.1.3. Food Grade
10.2.2. By Dosage
10.2.2.1. Single Dosage
10.2.2.2. Multi Dosage
10.2.3. By Application
10.2.3.1. Aesthetics
10.2.3.2. Osteoarthritis
10.2.3.3. Pharmaceutical Ingredients
10.2.3.4. Cosmetics
10.2.3.5. Dietary Supplements
10.2.3.6. Ophthalmology
10.2.4. By End-User
10.2.4.1. Pharmaceutical Industry
10.2.4.2. Dermatology & Cosmetics
10.2.4.3. Personal Care
10.2.4.4. Food
10.2.5. By Product
10.2.5.1. Hyaluronic Acid Injection
10.2.5.2. Hyaluronic Acid Sodium
10.2.6. By Region
10.2.6.1. North America
10.2.6.2. South America
10.2.6.3. Europe
10.2.6.4. Middle East & Africa
10.2.6.5. Asia-Pacific
10.2.7. By Company
10.2.7.1. Competition Characteristics
10.2.7.2. Market Share & Analysis
10.2.7.3. Competitive Matrix

11. North America Hyaluronic Acid Market Outlook, 2016-2026F

11.1. Market Size & Analysis
11.1.1. Revenues
11.2. Market Share & Analysis
11.2.1. By Grade
11.2.2. By Dosage
11.2.3. By Application
11.2.4. By End-User
11.2.5. By Product
11.2.6. By Country
11.2.6.1. The US
11.2.6.2. Canada
11.3. The US Hyaluronic Acid Market Outlook, 2016-2026F
11.3.1. Market Size & Analysis
11.3.1.1. Revenues
11.3.2. Market Share & Analysis
11.3.2.1. By Grade
11.3.2.2. By Dosage
11.3.2.3. By Application
11.3.2.4. By End-User
11.3.2.5. By Product
11.4. Canada Hyaluronic Acid Market Outlook, 2016-2026F
11.4.1. Market Size & Analysis
11.4.1.1. Revenues
11.4.2. Market Share & Analysis
11.4.2.1. By Grade
11.4.2.2. By Dosage
11.4.2.3. By Application
11.4.2.4. By End-User
11.4.2.5. By Product

12. South America Hyaluronic Acid Market Outlook, 2016-2026F

12.1. Market Size & Analysis
12.1.1. Revenues
12.2. Market Share & Analysis
12.2.1. By Grade
12.2.2. By Dosage
12.2.3. By Application
12.2.4. By End-User
12.2.5. By Product
12.2.6. By Country
12.2.6.1. Brazil
12.2.6.2. Mexico
12.3. Brazil Hyaluronic Acid Market Outlook, 2016-2026F
12.3.1. Market Size & Analysis
12.3.1.1. Revenues
12.3.2. Market Share & Analysis
12.3.2.1. By Grade
12.3.2.2. By Dosage
12.3.2.3. By Application
12.3.2.4. By End-User
12.3.2.5. By Product
12.4. Mexico Hyaluronic Acid Market Outlook, 2016-2026F
12.4.1. Market Size & Analysis
12.4.1.1. Revenues
12.4.2. Market Share & Analysis
12.4.2.1. By Grade
12.4.2.2. By Dosage
12.4.2.3. By Application
12.4.2.4. By End-User
12.4.2.5. By Product

13. Europe Hyaluronic Acid Market Outlook, 2016-2026F

13.1. Market Size & Analysis
13.1.1. Revenues
13.2. Market Share & Analysis
13.2.1. By Grade
13.2.2. By Dosage
13.2.3. By Application
13.2.4. By End-User
13.2.5. By Product
13.2.6. By Country
13.2.6.1. The UK
13.2.6.2. Italy
13.2.6.3. Germany
13.2.6.4. France
13.2.6.5. Spain
13.2.6.6. Others
13.3. The UK Hyaluronic Acid Market Outlook, 2016-2026F
13.3.1. Market Size & Analysis
13.3.1.1. Revenues
13.3.2. Market Share & Analysis
13.3.2.1. By Grade
13.3.2.2. By Dosage
13.3.2.3. By Application
13.3.2.4. By End-User
13.3.2.5. By Product
13.4. Italy Hyaluronic Acid Market Outlook, 2016-2026F
13.4.1. Market Size & Analysis
13.4.1.1. Revenues
13.4.2. Market Share & Analysis
13.4.2.1. By Grade
13.4.2.2. By Dosage
13.4.2.3. By Application
13.4.2.4. By End-User
13.4.2.5. By Product
13.5. Germany Hyaluronic Acid Market Outlook, 2016-2026F
13.5.1. Market Size & Analysis
13.5.1.1. Revenues
13.5.2. Market Share & Analysis
13.5.2.1. By Grade
13.5.2.2. By Dosage
13.5.2.3. By Application
13.5.2.4. By End-User
13.5.2.5. By Product
13.6. France Hyaluronic Acid Market Outlook, 2016-2026F
13.6.1. Market Size & Analysis
13.6.1.1. Revenues
13.6.2. Market Share & Analysis
13.6.2.1. By Grade
13.6.2.2. By Dosage
13.6.2.3. By Application
13.6.2.4. By End-User
13.6.2.5. By Product
13.7. Spain Hyaluronic Acid Market Outlook, 2016-2026F
13.7.1. Market Size & Analysis
13.7.1.1. Revenues
13.7.2. Market Share & Analysis
13.7.2.1. By Grade
13.7.2.2. By Dosage
13.7.2.3. By Application
13.7.2.4. By End-User
13.7.2.5. By Product

14. Middle East & Africa Hyaluronic Acid Market Outlook, 2016-2026F

14.1. Market Size & Analysis
14.1.1. Revenues
14.2. Market Share & Analysis
14.2.1. By Grade
14.2.2. By Dosage
14.2.3. By Application
14.2.4. By End-User
14.2.5. By Product
14.2.6. By Country
14.2.6.1. Saudi Arabia
14.2.6.2. South Africa
14.2.6.3. Rest of the Middle East & Africa
14.3. Saudi Arabia Hyaluronic Acid Market Outlook, 2016-2026F
14.3.1. Market Size & Analysis
14.3.1.1. Revenues
14.3.2. Market Share & Analysis
14.3.2.1. By Grade
14.3.2.2. By Dosage
14.3.2.3. By Application
14.3.2.4. By End-User
14.3.2.5. By Product
14.4. South Africa Hyaluronic Acid Market Outlook, 2016-2026F
14.4.1. Market Size & Analysis
14.4.1.1. Revenues
14.4.2. Market Share & Analysis
14.4.2.1. By Grade
14.4.2.2. By Dosage
14.4.2.3. By Application
14.4.2.4. By End-User
14.4.2.5. By Product

15. Asia-Pacific Hyaluronic Acid Market Outlook, 2016-2026F

15.1. Market Size & Analysis
15.1.1. Revenues
15.2. Market Share & Analysis
15.2.1. By Grade
15.2.2. By Dosage
15.2.3. By Application
15.2.4. By End-User
15.2.5. By Product
15.2.6. By Country
15.2.6.1. China
15.2.6.2. Japan
15.2.6.3. India
15.2.6.4. South Korea
15.2.6.5. Australia
15.2.6.6. Others
15.3. China Hyaluronic Acid Market Outlook, 2016-2026F
15.3.1. Market Size & Analysis
15.3.1.1. Revenues
15.3.2. Market Share & Analysis
15.3.2.1. By Grade
15.3.2.2. By Dosage
15.3.2.3. By Application
15.3.2.4. By End-User
15.3.2.5. By Product
15.4. Japan Hyaluronic Acid Market Outlook, 2016-2026F
15.4.1. Market Size & Analysis
15.4.1.1. Revenues
15.4.2. Market Share & Analysis
15.4.2.1. By Grade
15.4.2.2. By Dosage
15.4.2.3. By Application
15.4.2.4. By End-User
15.4.2.5. By Product
15.5. India Hyaluronic Acid Market Outlook, 2016-2026F
15.5.1. Market Size & Analysis
15.5.1.1. Revenues
15.5.2. Market Share & Analysis
15.5.2.1. By Dosage
15.5.2.2. By Application
15.5.2.3. By End-User
15.5.2.4. By Product
15.6. South Korea Hyaluronic Acid Market Outlook, 2016-2026F
15.6.1. Market Size & Analysis
15.6.1.1. Revenues
15.6.2. Market Share & Analysis
15.6.2.1. By Grade
15.6.2.2. By Dosage
15.6.2.3. By Application
15.6.2.4. By End-User
15.6.2.5. By Product
15.7. Australia Hyaluronic Acid Market Outlook, 2016-2026F
15.7.1. Market Size & Analysis
15.7.1.1. Revenues
15.7.2. Market Share & Analysis
15.7.2.1. By Grade
15.7.2.2. By Dosage
15.7.2.3. By Application
15.7.2.4. By End-User
15.7.2.5. By Product

16. Competition Outlook

16.1. Competition Matrix
16.1.1. Product/ Solution Portfolio
16.1.2. Target Markets
16.1.3. Target End Users
16.1.4. Research & Development
16.1.5. Strategic Alliances
16.1.6. Strategic Initiatives
16.2. Company Profiles of Top Companies (Business Description, Product Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)
16.2.1. Allergan Plc
16.2.2. Anika Therapeutics Inc
16.2.3. Sanofi
16.2.4. Fidia Farmaceutici
16.2.5. Seikagaku Corporation
16.2.6. Ferring Pharmaceuticals
16.2.7. Contipro Corporation
16.2.8. Kewpie Corporation

17. Disclaimer